Shahin Nasir, Shamanian Morteza, Kharaziha Mahshid
Materials Engineering Group, Pardis College, Isfahan University of Technology, Isfahan, Iran.
Department of Materials Engineering, Isfahan University of Technology, Isfahan, Iran.
J Biomed Mater Res A. 2025 Jul;113(7):e37953. doi: 10.1002/jbm.a.37953.
Plasma electrolytic oxidation (PEO) considerably affects controlling the degradation rate of magnesium-based implants to approach the healing period. However, the biological properties still require further improvement, particularly for blood-contact applications, such as cardiovascular stents. This research aims to study in vitro biological properties of the duplex diamond-like carbon (DLC)/plasma electrolytic oxidation (PEO) coatings as a function of various PEO middle layers for potential cardiovascular stent applications. To this aim, two different PEO coatings including silicate and phosphate compounds were applied on AZ31 substrate as middle-layers, and a top DLC layer with 1 μm thickness was successfully synthesized on them. Moreover, the role of different PEO interlayers on the degradation behavior, biocompatibility, hemocompatibility, and its mechanism are studied. Results showed a considerable decrease in degradation rate after applying the PEO process and the PEO-Ph revealed the optimized degradation performance in just PEO-coated samples. On the other side, the best degradation performance between duplex-coated samples was obtained for DLC/PEO-Si according to its higher diamond-like structure. Moreover, the viability of human umbilical vein endothelial cells on DLC/PEO-Ph was higher than that of the DLC/PEO-Si, which might be attributed to higher protein adsorption on its surface. In the case of hemocompatibility, a considerable decrease in hemolysis ratio along with remarkable improvement in clotting behavior was observed by applying the PEO process. However, the hemolysis ratio was reduced as being safe for blood-contact applications just for duplex-coated samples. In conclusion, a promising coating for blood-contact applications based on DLC/PEO in particular in the case of DLC/PEO-Si has been provided in this study.
微弧氧化(PEO)对控制镁基金属植入物的降解速率以接近愈合期有显著影响。然而,其生物学性能仍需进一步改善,特别是对于血液接触应用,如心血管支架。本研究旨在研究双层类金刚石碳(DLC)/微弧氧化(PEO)涂层的体外生物学性能,该涂层作为潜在心血管支架应用中各种PEO中间层的函数。为此,在AZ31基底上施加了两种不同的PEO涂层,包括硅酸盐和磷酸盐化合物作为中间层,并在其上成功合成了厚度为1μm的顶层DLC层。此外,还研究了不同PEO中间层对降解行为、生物相容性、血液相容性及其机制的作用。结果表明,经过PEO处理后降解速率显著降低,PEO-Ph在仅PEO涂层的样品中表现出最佳的降解性能。另一方面,根据其较高的类金刚石结构,DLC/PEO-Si在双层涂层样品中具有最佳的降解性能。此外,人脐静脉内皮细胞在DLC/PEO-Ph上的活力高于DLC/PEO-Si,这可能归因于其表面更高的蛋白质吸附。在血液相容性方面,通过PEO处理观察到溶血率显著降低,凝血行为显著改善。然而,仅双层涂层样品的溶血率降低,对血液接触应用是安全的。总之,本研究提供了一种有前景的基于DLC/PEO的血液接触应用涂层,特别是在DLC/PEO-Si的情况下。